Prognostic Significance of DR-70 Levels in Dysplastic Colorectal Polyps

被引:6
|
作者
Yesil, Atakan [1 ]
Abanonu, Gul Babacan [2 ]
Colak, Yasar [3 ]
Paker, Nurcan [4 ]
Gonen, Can [1 ]
机构
[1] Haydarpasa Numune Training & Res Hosp, Dept Gastroenterol, Istanbul, Turkey
[2] Haydarpasa Numune Training & Res Hosp, Dept Internal Med, Istanbul, Turkey
[3] Medeniyet Univ, Dept Gastroenterol, Istanbul, Turkey
[4] Duzen Labs, Istanbul, Turkey
关键词
D-DIMER LEVEL; CARCINOEMBRYONIC ANTIGEN; CANCER; IMMUNOASSAY; SURVEILLANCE; RESECTION; UPDATE; TRACT; SERUM; FDP;
D O I
10.1155/2013/275392
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. To investigate the relationship between DR-70 serum levels and dysplastic colon polyps. Materials and Methods. A total of 130 patients with adenomatous polyps detected by colonoscopy and divided into two groups including low versus high grade polyp, along with 50 healthy blood donors were included in the study. Blood samples from each participant were analyzed for serum CEA and DR-70 levels. Results. No statistically significant differences were observed between the two groups in terms of age or gender. The median DR-70 level was 0.5 mu g/mL in the healthy control group and 1.1 mu g/mL in group 1b (i.e., the high grade polyp) (P < 0.001). DR-70 was higher in group 1b as compared to group 1a (P < 0.001). However, the median DR-70 values for the low grade polyp group (i.e., group 1a) and the control group were similar (P = 0.067). In order to determine independent predictors of high grade dysplasia, CEA, DR-70, polyp size, and age parameters were subjected to multiple logistical regression analyses via the Enter method; the model was statistically significant (P < 0.001). Conclusions. DR-70, a marker used to measure FDP, which is generated by all major cancers, is a potential marker to identify patients with advanced adenomatous polyps, that is, precursors of colorectal cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms
    Ke, Chiao-Hsu
    Lin, Chen-Si
    Sio, Ka-Mei
    Wu, Chun-Hung
    Xia, Yuan-Yuan
    Lee, Jih-Jong
    Hu, Chin-Hao
    Liu, Cheng-Chi
    Liaw, Bor-Song
    Cheng, Chiao-Lei
    Lin, Keng-Hsuan
    Wang, Yu-Shan
    VETERINARY QUARTERLY, 2024, 44 (01) : 1 - 10
  • [2] Serum AMDL DR-70 levels: a new concept in the diagnosis and follow-up of colorectal carcinoma
    Saridemir, Serdar
    Gueven, Hikmet E.
    Aksel, Buelent
    Dogan, Luetfi
    BIOMARKERS IN MEDICINE, 2020, 14 (08) : 621 - 628
  • [3] DR-70: A PROMISING BIOMARKER FOR THE DETECTION OF LUNG CANCER
    Ozgul, G.
    Koc, A. S.
    Turan, D.
    Kucuk, S. H.
    Ozsoy, S.
    Baydili, K. N.
    Guler, E. M.
    Ozgul, M. A.
    Kansu, Z. E.
    Seyhan, E. C.
    WORLD CANCER RESEARCH JOURNAL, 2021, 8
  • [4] Diagnostic value of serum fibrin degradation complex DR-70 combined with conventional tumor biomarkers in colorectal cancer
    Wang, Xiaoxia
    Wei, Wei
    Hua, Nanni
    Li, Chunyan
    Yu, Lili
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (07)
  • [5] Serum DR-70 as Biomarker in Breast Cancer
    Buldanli, Mehmet Zeki
    Ozemir, Ibrahim Ali
    Colapkulu, Nuray
    Baysal, Hakan
    Ekinci, Ozgur
    Yener, Oktay
    Kahraman, Nevin Genc
    Alimoglu, Orhan
    INDIAN JOURNAL OF SURGERY, 2022, 84 (06) : 1284 - 1291
  • [6] DR-70 immunoassay for the surveillance of hepatocellular carcinoma
    Lin, Shan-Zu
    Chen, Chun-Chia
    Lee, Kuei-Chuan
    Tseng, Chih-Wei
    Lin, Hsiao-Yi
    Chen, Yi-Chou
    Lin, Han-Chieh
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (03) : 547 - 552
  • [7] Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms
    Ke, Chiao-Hsu
    Sio, Ka-Mei
    Wu, Chun-Hung
    Xia, Yuan-Yuan
    Lee, Jih-Jong
    Hu, Chin-Hao
    Liu, Cheng-Chi
    Lu, Chueh-Ling
    Cheng, Chiao-Lei
    Lin, Keng-Hsuan
    Tomiyasu, Hirotaka
    Wang, Yu-Shan
    Lin, Chen-Si
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2023, 37 (06) : 2391 - 2401
  • [8] Combination of serum CST4 and DR-70 contributes to early diagnosis of colorectal cancer
    Cai, Liqing
    Tu, Mingshu
    Yin, Xiaoqing
    Zhang, Songgao
    Zhuang, Wanzhen
    Xia, Yu
    Zhang, Yi
    Zhang, Liangming
    Yu, Lili
    Chi, Liangjie
    Huang, Yi
    CLINICA CHIMICA ACTA, 2022, 531 : 318 - 324
  • [9] ADVANTAGES OF THE AMDL-ELISA DR-70 (FDP) ASSAY OVER CARCINOEMBRYONIC ANTIGEN (CEA) FOR MONITORING COLORECTAL CANCER PATIENTS
    Small-Howard, Andrea L.
    Harris, Holden
    JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2010, 31 (02) : 131 - 147
  • [10] DR-70 as a novel diagnostic biomarker for gastric cancer
    Arhan, Mehmet
    Yilmaz, Hulya
    Onal, Ibrahim K.
    Kocabiyik, Murat
    Erdal, Harun
    Ibis, Mehmet
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (06) : 480 - 483